Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Loperamide Hydrochloride Capsules USP, 2 mg, a generic version of Imodium®*...

Parsippany, New Jersey. Edenbridge Pharmaceuticals is aware of interest in and media reports related to the potential use of Ivermectin for the prevention and/or treatment of COVID-19. Edenbridge's Ivermectin tablets, USP (3mg) are not approved by the U.S. Food and...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has successfully filed a 505(b)(2) New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for methenamine mandelate tablets USP, 500mg and 1,000mg. This filing joins another...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Aminocaproic Acid Tablets USP, 500 mg, a generic version of Amicar®* tablets,...

Parsippany, New Jersey. Edenbridge Pharmaceuticals announces the launch of its miglustat capsules 100mg. Generic version of Zavesca®* capsules being distributed by Orsini Specialty Pharmacy and offered with a co-pay program for eligible patients. Edenbridge...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that the World Health Organization (WHO) has added Edenbridge's Ivermectin Tablets USP (3mg) to its Prequalified Medicines List. This marks the first ivermectin product in the world to be added to the...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP (2.5mg/6.25mg,...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Diltiazem Hydrochloride Tablets, USP (30 mg, 60 mg, 90 mg, and 120 mg), a...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Albendazole Tablets USP 200mg, a generic version of Albenza®* tablets...

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Etodolac Tablets, USP, a generic version of Lodine®* tablets (Etodolac...